Glucose News and Research

RSS

Gut probiotic Christensenella tenuis reduces endotoxemia and improves metabolism in obese mice

This study is reported by the team of Professor Shuang-jiang Liu from Shandong University. The study reveals that the gut probiotic Christensenella tenuis significantly alleviates endotoxemia and metabolic disorders in a diet-induced obesity (DIO) mouse model by modulating gut bile acids (BAs) metabolism and suppressing lipopolysaccharide (LPS) translocation across the gut barrier.

26 Sep 2025

Daily walnut snacks fail to lower inflammation in adults

Research on daily walnut intake showed no significant effects on inflammatory markers or antioxidant capacity in middle-aged individuals with metabolic risks.

26 Sep 2025

Cruciferous vegetables beat root vegetables in stabilizing blood sugar

The VEgetableS for vaScular hEaLth study reveals cruciferous vegetables improve glycemic control, emphasizing their importance in dietary strategies for health.

25 Sep 2025

Eating earlier in the day could help you lose more weight than later meals

Time-restricted eating impacts body composition and performance, with early eating linked to greater weight loss and late eating enhancing anaerobic power.

25 Sep 2025

New study suggests a connection between soft drinks and depression via the microbiome

A new study involving the German Center for Diabetes Research (DZD) provides strong evidence that sugary drinks affect not only metabolic but also mental health – especially in women. This effect is probably mediated by the sensitive microbiome of the intestine.

25 Sep 2025

Mango shows unexpected benefits for diabetes prevention

If presented with two snacks, one containing seven grams of sugar and another with over 30 grams of sugar, choosing the healthier option should be a no-brainer, correct? Well, maybe not. Less sugar is not automatically healthier.

24 Sep 2025

Innovative technique could reveal Alzheimer’s before symptoms appear

NAU researchers are experimenting with new technology that could help medical providers easily detect Alzheimer's disease early and prevent its advance.

24 Sep 2025

Global cancer cases and deaths expected to soar by 2050 despite advances in treatment

There has been a rapid increase in the global number of cancer cases and deaths between 1990 and 2023, despite advances in cancer treatment and efforts to tackle cancer risk factors over that same time period.

24 Sep 2025

Blood and brain biomarkers transform how doctors confirm Alzheimer’s disease

A new Lancet review proposes a three-wave diagnostic pathway that combines clinical expertise with blood, CSF, and PET biomarkers. This approach aims to deliver earlier, more accurate, and more equitable Alzheimer’s disease diagnosis worldwide.

24 Sep 2025

How food choices and cooking methods drive brain inflammation and disease

Researchers reviewing evidence in NeuroSci show how dietary AGEs and their interaction with RAGE drive oxidative stress, inflammation, and neurodegeneration. They highlight how cooking methods and diet choices could lower AGE burden and protect brain health, while calling for rigorous clinical trials.

24 Sep 2025

Scientists outline how future therapies could change type 1 diabetes care

Researchers writing in The Lancet review breakthroughs in type 1 diabetes treatment, from immunotherapies that delay onset to stem-cell β-cell replacement and automated insulin delivery. They stress that equitable access, validated surrogate endpoints, and scalable technologies are crucial for lasting impact.

24 Sep 2025

Georgia State scientist receives $25,000 grant to develop mechanisms for treating obesity

Chong Hyun Shin, a research associate professor in the Institute for Biomedical Sciences at Georgia State University, has received a $25,000 grant to develop mechanisms for treating obesity and obesity-related metabolic dysfunctions.

23 Sep 2025

How much apple cider vinegar reduces weight? Meta-analysis points to 30 mL daily

A new meta-analysis of randomized controlled trials shows apple cider vinegar can modestly but significantly reduce body weight, BMI, and waist circumference in adults, particularly those with obesity or type 2 diabetes.

22 Sep 2025

Yokogawa and Repligen partner to enhance process analytical technology

Yokogawa Corporation of America and Repligen announce a collaboration to integrate Yokogawa's OpreX Bio Pilot with Repligen's MAVERICK®, enhancing automated control of glucose and lactate levels in cell cultures.

22 Sep 2025

New quintuple agonist shows promise for treating obesity and type 2 diabetes

Much excitement has built in recent years on the new class of incretin drugs that include glucagon-like-peptide-1 inhibitor (single agonists such as semaglutide) and also dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonists (dual agonists such tirzepatide).

21 Sep 2025

Glucose-fructose mix found in sugary drinks fuels colorectal cancer metastasis

A new study from researchers at The University of Texas MD Anderson Cancer Center shows that the glucose-fructose mix found in sugary drinks directly fuels metastasis in preclinical models of advanced colorectal cancer.

19 Sep 2025

Study points to a surprising new ally in the fight against type 2 diabetes

A new study from Duke University School of Medicine is challenging long-standing views on blood sugar regulation - and pointing to a surprising new ally in the fight against type 2 diabetes.

19 Sep 2025

New study warns of millions of undiagnosed and missing people with type 1 diabetes

The global type 1 diabetes (T1D) burden continues to increase rapidly driven by rising cases, ageing populations, improved diagnosis and falling death rates, according to the results of a new modeling study being presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Vienna (15-19 Sept).

19 Sep 2025

Oral drug baricitinib shows promise in slowing early type 1 diabetes progression

In 2023, the groundbreaking Australian BANDIT (Baricitinib in New Onset Type 1 Diabetes) trial [1] reported that a daily pill of baricitinib, commonly prescribed for rheumatoid arthritis and alopecia, could safely preserve the body's own insulin production and slow the progression of type 1 diabetes (T1D) in people recently diagnosed with the condition.

19 Sep 2025

Can eating style affect how well GLP-1 drugs control diabetes and weight?

Research indicates that external eating behavior is a key predictor of weight loss in type 2 diabetes patients receiving GLP-1 receptor agonists.

19 Sep 2025

Glucose News and Research

Gut probiotic Christensenella tenuis reduces endotoxemia and improves metabolism in obese mice

Daily walnut snacks fail to lower inflammation in adults

Cruciferous vegetables beat root vegetables in stabilizing blood sugar

Eating earlier in the day could help you lose more weight than later meals

New study suggests a connection between soft drinks and depression via the microbiome

Mango shows unexpected benefits for diabetes prevention

Innovative technique could reveal Alzheimer’s before symptoms appear

Global cancer cases and deaths expected to soar by 2050 despite advances in treatment

Blood and brain biomarkers transform how doctors confirm Alzheimer’s disease

How food choices and cooking methods drive brain inflammation and disease

Scientists outline how future therapies could change type 1 diabetes care

Georgia State scientist receives $25,000 grant to develop mechanisms for treating obesity

How much apple cider vinegar reduces weight? Meta-analysis points to 30 mL daily

Yokogawa and Repligen partner to enhance process analytical technology

New quintuple agonist shows promise for treating obesity and type 2 diabetes

Glucose-fructose mix found in sugary drinks fuels colorectal cancer metastasis

Study points to a surprising new ally in the fight against type 2 diabetes

New study warns of millions of undiagnosed and missing people with type 1 diabetes

Oral drug baricitinib shows promise in slowing early type 1 diabetes progression

Can eating style affect how well GLP-1 drugs control diabetes and weight?

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News